Streptomyces fulvoviridis A933 17M9 1501 is an A933 acylase-defective mutant derived from S. fulvoviridis A933 17M9 and thus produces the OA-6129 group of carbapenems and carbapenams. By further mutation of mutant 1501, 4 types of mutants (OA-6129 A+Bl +B2 producers; OA-6129 A+B2 producers; an OA-6129 A producer; non-producers) were obtained. The second type of mutant strains 4N 3607, 5NA 3949-40 and 5NE 252 proved useful for the fermentative production of carbapenem OA-6129B2. These results of mutagenesis demonstrated that the sequence of carbapenem bioconversion in the horizontal route was hydroxylation at C-8-HSomerization at C-6-»sulfation at C-8 hydroxyl.
899Carbapenems are a novel class of /3-lactam compounds that possess an extremely wide spectrum of potent antimicrobial activity against Gram-positive and Gram-negative bacteria. Many carbapenem-producing microbes have been reported to date which can be classified into three groups of microorganisms (unicellular bacteria, Streptomyces cattleya, and other streptomycetes), based on their microbiological characteristics and product analyses. This paper is concerned with the last group of carbapenem-producing streptomycetes, and more particularly, with Streptomyces fulvo viridis. 1 "Â s carbapenems have more chiral centers than penicillins and cephalosporins, the production of a clinically useful carbapenem derivative will probably be carried out more economically by employing a naturally occurring carbapenem compound as a starting material rather than by total synthesis. OA-6129 B2 was chosen as a carbapenem intermediate useful for chemical derivation.^Presently available information of carbapenem biosynthesis, however, indicates that carbapenem-producing streptomycetes other than S. cattleya are capable of forming 42 carbapenem and carbapenam compounds.3»4) It is not practical to attempt to preferentially produce one carbapenem component, such as PS-5, among the 42 known compounds simply by manipulating fermentation conditions. A promising approach to production of OA-6129B2 is to utilize specifically-blocked mutants which accumulate OA-6129 B2 as a single major product. As S. fulvoviridis A933 17M9 1501 produces only the OA-6129 group of carbapenems and carbapenams among the 42 known compounds,6) it was chosen as the parent strain for mutagenic preparation of OA-6129 carbapenem-producing blocked mutants in the present study.This paper describes isolation of 4 types of blocked mutants obtained by mutagenesis of S. fulvoviridis A933 17M91501. Results of product analysis in these mutants allowed us to conclude that the horizontal sequence of bioconversion among the OA-6129 group of carbapenems is as follows: OA-6129 A is hydroxylated at C-8 to form OA-6129 B2 (type III mutant); OA-6129 B2 is isomerized at C-6 to give OA-6129 Bl (type II mutants); and OA-6129 Bl is sulfated at the C-8 hydroxyl group